JW (Cayman) Therapeutics Co Ltd
HKEX:2126

Watchlist Manager
JW (Cayman) Therapeutics Co Ltd Logo
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
Watchlist
Price: 2.82 HKD Market Closed
Market Cap: 1.2B HKD

Intrinsic Value

The intrinsic value of one JW (Cayman) Therapeutics Co Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 2.82 HKD, JW (Cayman) Therapeutics Co Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

JW (Cayman) Therapeutics Co Ltd Intrinsic Value
HIDDEN
Show
Base Case Scenario

Valuation History
JW (Cayman) Therapeutics Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

JW (Cayman) Therapeutics Co Ltd looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if JW (Cayman) Therapeutics Co Ltd is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about JW (Cayman) Therapeutics Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is JW (Cayman) Therapeutics Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for JW (Cayman) Therapeutics Co Ltd.

Explain Valuation
Compare JW (Cayman) Therapeutics Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about JW (Cayman) Therapeutics Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
JW (Cayman) Therapeutics Co Ltd

Current Assets 747m
Cash & Short-Term Investments 646.9m
Receivables 25.1m
Other Current Assets 75.1m
Non-Current Assets 672.4m
PP&E 241.9m
Intangibles 417.5m
Other Non-Current Assets 12.9m
Current Liabilities 470.3m
Accounts Payable 149.9m
Accrued Liabilities 25.5m
Other Current Liabilities 294.9m
Non-Current Liabilities 40.5m
Long-Term Debt 40.5m
Efficiency

Free Cash Flow Analysis
JW (Cayman) Therapeutics Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
JW (Cayman) Therapeutics Co Ltd

Revenue
177.7m CNY
Cost of Revenue
-79.1m CNY
Gross Profit
98.7m CNY
Operating Expenses
-563.5m CNY
Operating Income
-464.8m CNY
Other Expenses
-152.9m CNY
Net Income
-617.6m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

JW (Cayman) Therapeutics Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Operating Margin is Increasing
Sustainable 3Y Average Gross Margin
Gross Margin is Increasing
hidden
Profitability
Score

JW (Cayman) Therapeutics Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

JW (Cayman) Therapeutics Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Short-Term Solvency
hidden
Solvency
Score

JW (Cayman) Therapeutics Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
JW (Cayman) Therapeutics Co Ltd

Wall Street analysts forecast JW (Cayman) Therapeutics Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JW (Cayman) Therapeutics Co Ltd is 6.16 HKD with a low forecast of 6.1 HKD and a high forecast of 6.34 HKD.

Lowest
Price Target
6.1 HKD
116% Upside
Average
Price Target
6.16 HKD
118% Upside
Highest
Price Target
6.34 HKD
125% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

JW (Cayman) Therapeutics Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for JW (Cayman) Therapeutics Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one JW (Cayman) Therapeutics Co Ltd stock?

The intrinsic value of one JW (Cayman) Therapeutics Co Ltd stock under the Base Case scenario is hidden HKD.

Is JW (Cayman) Therapeutics Co Ltd stock undervalued or overvalued?

Compared to the current market price of 2.82 HKD, JW (Cayman) Therapeutics Co Ltd is hidden .

Back to Top